Clinical Trials Logo

Urinary Incontinence, Stress clinical trials

View clinical trials related to Urinary Incontinence, Stress.

Filter by:
  • Active, not recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06269016 Active, not recruiting - Clinical trials for Stress Urinary Incontinence

Effect of Hip Strengthening Exercises and Pelvic Floor Exercises on Stress Urinary Incontinence in Postnatal Women

Start date: February 20, 2023
Phase: N/A
Study type: Interventional

this study will investigate effect of hip strengthening exercises and pelvic floor exercises on stress urinary incontinence in postnatal women. Clinical practice guidelines recommend PFMT as the first-line treatment for female SUI . Also, it has been speculated that the hip muscles are involved in the continence mechanism and that their deficiency could destabilize the normal function of the system. The addition of hip muscle exercises, regardless of PFM contractions, aimed to improve muscular condition for the motor or synergic strategies in PFM contraction. Secondary effects of these techniques, such as the influence of passive lumbar rotational mobilization in improving hip flexor strength, have been of high interest in physiotherapy in general

NCT ID: NCT06224335 Active, not recruiting - Clinical trials for Stress Urinary Incontinence

Measurement of Intravaginal and Intra-abdominal Pressure and Pad Test During Sports Activities (SPORTVAGPRES)

SPORTVAGPRES
Start date: September 28, 2023
Phase:
Study type: Observational

To compare the impact of selected physical activities on pelvic floor and stress urinary incontinence in sportwoman.

NCT ID: NCT05787730 Active, not recruiting - Clinical trials for Urinary Incontinence,Stress

Ultrasound and Cure Rate Three Months and 15 Years After TOT-procedure

Start date: January 1, 2005
Phase: N/A
Study type: Interventional

The study is a cohort study. Between 2005 and 2008, a total of 54 patients were examined with ultrasound before and after TOT surgery. The collected data has not been previously published. Now these same patients are to be examined again with a more advanced ultrasound device. The subjects underwent a urogynecological ultrasound examination before surgery and during the follow-up examination 2-3 months after the procedure. In connection with the follow-up examination, the success of the procedure and the satisfaction of the patients have been evaluated. The data was collected between 2005 and 2008, and the purpose is to invite the patients in question to a research visit, so that the long-term effect of the procedure can be evaluated and the position of the band can be determined with a newer technology ultrasound device. The patients' subjective satisfaction with the procedure is assessed using questionnaires.

NCT ID: NCT05547672 Active, not recruiting - Clinical trials for Urinary Incontinence,Stress

Clinical Investigation to Assess a New Artificial Urinary Sphincter to Treat Urinary Incontinence in Men

SOPHIA
Start date: August 31, 2022
Phase: N/A
Study type: Interventional

Prospective multicenter study designed to test the feasibility of the UroMems Artificial Urinary Sphincter.

NCT ID: NCT05390970 Active, not recruiting - Clinical trials for Urinary Incontinence

Platelet-Rich Plasma for Stress Urinary Incontinence

Start date: May 23, 2022
Phase: N/A
Study type: Interventional

The aim of this randomized controlled trial study is to evaluate the efficacy and safety of platelet-rich plasma (PRP) in the treatment of female stress urinary incontinence (SUI), compared to placebo. Subjects will undergo an injection of PRP (or injectable saline placebo) into the anterior vaginal wall in the office. Primary outcomes will include a negative urinary stress test plus improvement with the Patient Global Impression of Improvement (PGI-I) at 6-months. Secondary outcomes will include the Female Sexual Function Index (FSFI), the Incontinence Quality of life (I-QOL), Questionnaire for Urinary Incontinence Diagnosis (QUID), and the visual analog scale for pain.

NCT ID: NCT05207189 Active, not recruiting - Clinical trials for Stress Urinary Incontinence

Biological Sling Allograft (UVT) for the Treatment of Urinary Incontinence in Women Presenting With Synthetic Sling Complications

Start date: November 8, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this open, multi center trial is to evaluate a new biological replacement for synthetic slings in the treatment of female stress urinary incontinence.

NCT ID: NCT05182632 Active, not recruiting - Clinical trials for Urinary Incontinence

Tele-rehabilitation Group Program for Urinary Incontinence in Older Women

Start date: March 6, 2021
Phase: N/A
Study type: Interventional

The recommended treatment for urinary incontinence (UI) in women is individualized pelvic floor muscle training (PFMT), a costly and resource-intensive approach; one Canada is currently unable to meet. A recent non-inferiority randomized controlled trial just confirmed that group-based PFMT is equally effective but less resource-intensive (more cost-effective) than individual PFMT to treat UI in older women (ClinicalTrials.gov Identifier: NCT02039830). In times of COVID-19 however, with the Quebec, Canada's public health authorities preventing gatherings to stop the virus' spread, the potential of in-person group approaches is temporarily limited. It is thus important to develop innovative ways to deliver this first-line treatment remotely, particularly for those confined at home for whom UI can have a detrimental impact on physical health and quality of life. Ensuring an online option for group-based PFMT would also allow to increase the accessibility of UI treatment for women living in rural or remote areas in Canada, where pelvic floor rehabilitation services are not available or scarce. To this end, this study will assess the feasibility, acceptability and effects of a tele-rehabilitation PFMT group program for UI in older women.

NCT ID: NCT04985799 Active, not recruiting - Clinical trials for Stress Urinary Incontinence

Comparing KIM to TVT Exact Sling

Start date: August 11, 2021
Phase: N/A
Study type: Interventional

To assess to the non-inferiority of the retropubic Neomedic Knotless Incontinence Mesh (KIM) sling compared to the Gynecare Tension-free Vaginal Tape (TVT) Exact sling. Participants: Women 21 years or older with a diagnosis of stress urinary incontinence (SUI) or mixed urinary incontinence (MUI) with objective evidence of SUI planning surgery for stress urinary incontinence. Procedures (methods): Patients will be randomized to receive either the Gynecare TVT Exact sling or the retropubic Neomedic KIM sling. Patients will be followed for 1 year postoperatively.

NCT ID: NCT04881721 Active, not recruiting - Clinical trials for Stress Urinary Incontinence

Mesh-free Suture Urethropexy for Treating Stress Urinary Incontinence, Efficacy and Durability Trial

Start date: August 25, 2021
Phase:
Study type: Observational

In this proposed study, the investigators aim to evaluate a modified suture urethropexy technique for the treatment of female stress urinary incontinence. Participants will be followed with postoperative visits after 2 weeks, 2 months, and 12 months. Pelvic floor ultrasound imaging will be performed before surgery and after 2 months and 12 months, to evaluate urethral mobility.

NCT ID: NCT04643353 Active, not recruiting - Clinical trials for Urinary Incontinence,Stress

Use of Non-ablative Vaginal Erbium YAG Laser for the Treatment of Stress Urinary Incontinence.

VELSUI
Start date: November 27, 2020
Phase: N/A
Study type: Interventional

This is a single center, investigator initiated study, sponsored by the UZ Leuven, Leuven, Belgium; comparing laser treatment to pelvic floor exercises (PFE). Women with symptomatic stress urinary incontinence who seek for a conservative treatment, with no history of previous incontinence-surgery will be randomised to either the laser-arm or the PFE-arm. There are 3 visits (with a maximum of 6 visits) where vaginal application of laser will be performed, with a 4-weeks interval. Each application lasts around 15 minutes. The vaginal laser procedure will be performed in an outpatient setting, not requiring any specific preparation, analgesia or anesthesia, by one of two experienced operators. The primary objective is to evaluate the effects of VEL treatment for the subjective cure or improvement of SUI. The secondary objectives are to measure objective outcomes, to register any adverse events, and to determine for how long the effects of laser are sustained, with a maximum of two years.